Tg Therapeutics' 15-minute chart shows KDJ Death Cross, Bearish Marubozu signal.
ByAinvest
Wednesday, Aug 6, 2025 12:04 pm ET1min read
EFSI--
The KDJ Death Cross and Bearish Marubozu pattern have been observed in other stocks as well, such as Eagle Financial, Telix, and SABESP, which have shown similar bearish signals [2][3]. Investors should closely monitor TG Therapeutics for further signs of downward trends.
In addition to the technical indicators, TG Therapeutics recently reported its second-quarter earnings, which were mixed. The company reported earnings of 17 cents per share, substantially missing the Zacks Consensus Estimate of 32 cents. Revenues in the second quarter totaled $141.1 million, up almost 92% year over year, driven by the strong demand for the company’s sole marketed drug, Briumvi (ublituximab-xiiy) [4].
The recent technical analysis and earnings report suggest that investors should be cautious about TG Therapeutics stock. The bearish momentum indicated by the KDJ Death Cross and Bearish Marubozu pattern, along with the mixed earnings announcement, may signal further potential declines in the stock price.
References:
[1] https://www.ainvest.com/news/trip-15-minute-chart-triggers-kdj-death-cross-bearish-marubozu-2508/
[2] https://www.ainvest.com/news/eagle-financial-15min-chart-triggers-kdj-death-cross-bearish-marubozu-signal-2507/
[3] https://www.ainvest.com/news/telix-15min-chart-triggers-kdj-death-cross-bearish-marubozu-pattern-2507/
[4] https://www.barchart.com/story/news/33894778/tgtx-down-as-q2-earnings-miss-mark-briumvi-sales-drive-top-line
SBS--
TGTX--
TLX--
At Tg Therapeutics, the 15-minute chart has recently indicated a KDJ Death Cross and a Bearish Marubozu, which occurred on August 6th at 12:00. This suggests that the momentum of the stock price is shifting in a downward direction and has the potential to further decline. The sellers are currently in control of the market, and it is likely that this bearish momentum will continue.
TG Therapeutics (TGTX) has recently experienced a significant shift in its stock price momentum, as indicated by a KDJ Death Cross and a Bearish Marubozu on its 15-minute chart. This technical analysis suggests a potential downward trend, with sellers currently dominating the market. The KDJ Death Cross, a reversal pattern, occurs when the K-line crosses below the J-line on the KDJ indicator, signaling a potential trend reversal [1]. The Bearish Marubozu pattern, characterized by a single candle with no upper or lower wick, indicates that the stock has been trading within a narrow range, with sellers dominating the market [1].The KDJ Death Cross and Bearish Marubozu pattern have been observed in other stocks as well, such as Eagle Financial, Telix, and SABESP, which have shown similar bearish signals [2][3]. Investors should closely monitor TG Therapeutics for further signs of downward trends.
In addition to the technical indicators, TG Therapeutics recently reported its second-quarter earnings, which were mixed. The company reported earnings of 17 cents per share, substantially missing the Zacks Consensus Estimate of 32 cents. Revenues in the second quarter totaled $141.1 million, up almost 92% year over year, driven by the strong demand for the company’s sole marketed drug, Briumvi (ublituximab-xiiy) [4].
The recent technical analysis and earnings report suggest that investors should be cautious about TG Therapeutics stock. The bearish momentum indicated by the KDJ Death Cross and Bearish Marubozu pattern, along with the mixed earnings announcement, may signal further potential declines in the stock price.
References:
[1] https://www.ainvest.com/news/trip-15-minute-chart-triggers-kdj-death-cross-bearish-marubozu-2508/
[2] https://www.ainvest.com/news/eagle-financial-15min-chart-triggers-kdj-death-cross-bearish-marubozu-signal-2507/
[3] https://www.ainvest.com/news/telix-15min-chart-triggers-kdj-death-cross-bearish-marubozu-pattern-2507/
[4] https://www.barchart.com/story/news/33894778/tgtx-down-as-q2-earnings-miss-mark-briumvi-sales-drive-top-line
Stay ahead of the market.
Get curated U.S. market news, insights and key dates delivered to your inbox.
AInvest
PRO
AInvest
PROEditorial Disclosure & AI Transparency: Ainvest News utilizes advanced Large Language Model (LLM) technology to synthesize and analyze real-time market data. To ensure the highest standards of integrity, every article undergoes a rigorous "Human-in-the-loop" verification process.
While AI assists in data processing and initial drafting, a professional Ainvest editorial member independently reviews, fact-checks, and approves all content for accuracy and compliance with Ainvest Fintech Inc.’s editorial standards. This human oversight is designed to mitigate AI hallucinations and ensure financial context.
Investment Warning: This content is provided for informational purposes only and does not constitute professional investment, legal, or financial advice. Markets involve inherent risks. Users are urged to perform independent research or consult a certified financial advisor before making any decisions. Ainvest Fintech Inc. disclaims all liability for actions taken based on this information. Found an error?Report an Issue

Comments
No comments yet